Personalized cancer vaccine shows promise, experts weigh in
Moderna developed the vaccine with Merck and tested it together with Keytruda, a common immunotherapy treatment for melanoma. If regulators approve the vaccine, thousands of patients who have had high-risk melanoma tumors removed could benefit from it as soon as next year, Moderna President Stephen Hoge said.
Top Videos
Personalized cancer vaccine shows promise, experts weigh in
Amazon aiming to expand drone delivery to new cities
Dearborn police chief discusses protest response
MDHHS vaccine guidelines unchanged amid Trump's new order
Meta faces landmark child safety trial
Sweet ending to tough road for Detroit family gifted a home
Milford business owner filed motion to get horses back
Macomb County teacher charged with possessing child abusive materials and drugs
Blues in the Woods: Free music, family fun and Detroit soul in Harper Woods
Back-to-school reality check: Artificial intelligence, cell phones, bullying and the challenges kids face
Surrogacy legal battle involving McKenna West raises questions about contracts, parental rights and pregnancy decisions
Happy Birthday Deena from Good Day Detroit
Jars Cannabis business, Madison Heights clash over Flock camera
Madison Heights debates removal of Flock camera pointed at dispensary
Dearborn community responds after anti-Muslim protests
St. Clair Shores man faces hefty boat docking fines
Teen arrested after deadly stabbing in Detroit
Dearborn mayor reflects on tense anti-Islam protests
Aftermath from Dearborn demonstration includes several arrests
KKK flyers found in Dearborn Heights neighborhood
Terror @ Taylortown horror convention starts Friday
Arrests made after alt-right crusader protest in Dearborn
Aftermath of anti-Muslim protest at Dearborn City Council meeting
US Senate Candidate El-Sayed speaks on anti-Islam protest in Dearborn
